Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Bonn, Germany.
EuroIntervention. 2012 Sep;8 Suppl Q:Q94-6. doi: 10.4244/EIJV8SQA17.
The first member of the next generation CoreValve "family" is the 23 mm CoreValve® Evolut™ (Medtronic, Minneapolis, MN, USA), which is indicated for an annulus range of 18 mm to 20 mm and extends the spectrum of patients with aortic stenosis that can be treated with the self-expanding CoreValve bioprosthesis. The Core-Valve Evolut provides several technical refinements and is designed to enable re-capturability in the future. Here, we report on the first case in a 93-year-old female patient who was implanted at the University Hospital Bonn, Germany, on June 1st, 2012.
新一代 CoreValve“家族”的首个成员是 23 毫米 CoreValve® Evolut™（美敦力公司，明尼苏达州明尼阿波利斯市，美国），它适用于 18 毫米至 20 毫米的瓣环范围，并扩展了可使用自扩张 CoreValve 生物瓣治疗的主动脉瓣狭窄患者的范围。Core-Valve Evolut 提供了多项技术改进，旨在实现未来的可重新捕获能力。在此，我们报告了德国波恩大学医院于 2012 年 6 月 1 日为一名 93 岁女性患者植入该器械的首例病例。
